SCHEMBL9901077

SCHEMBL9901077

Cc1cc(Oc2ccc(N)cc2)c2c(C)onc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TEAD4 Q15561 1/20 0.42
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MITF O75030 1/20 0.34
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
NLRP1 Q9C000 1/20 0.34
NOD2 Q9HC29 1/20 0.34
PDE7A Q13946 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9900752 0.81 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL9905731 0.77 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL31448066 0.68 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL11089170 0.68 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL24173764 0.67 DYRK1A (0.36) ALDH1A1SMN1; SMN2MAPTPOLBMEN1
SCHEMBL17865520 0.66 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL19829397 0.65 ALDH1A1 (0.95) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL6690095 0.64 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL22874622 0.64 TEAD4 (0.57) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1
SCHEMBL554766 0.64 TEAD4 (0.57) ALDH1A1SMN1; SMN2TEAD4MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649066-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS Autifony Therapeutics Limited (GB) 2013-10-16 EP disclosed
WO-2012076877-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS AUTIFONY THERAPEUTICS LIMITED (GB) 2012-06-14 WO disclosed